Alpha-1-antitrypsin deficiency: A new paradigm for hepatocellular carcinoma in genetic liver disease

Hepatology

Volumn 42, Issue 3, 2005, Pages 514-521

  Rudnick, David A ^a   Perlmutter, David H ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; AUTOPHAGY; CANCER SURVIVAL; CELL DAMAGE; CELL PROLIFERATION; CHROMOSOME 8; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA MODIFICATION; ENDOPLASMIC RETICULUM; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC DISORDER; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SHORT SURVEY; SIGNAL TRANSDUCTION; STIMULATION; TELOMERE;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MUTATION;

EID: 24144496018     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20815     Document Type: Short Survey

References (49)

1. Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in α1-antitrypsin deficiency. N Engl J Med 1986;314:736-739.
2. Perlmutter DH. Liver injury in α1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. J Clin Invest 2002;110:1579-1583.
3. Dycaico MJ, Grant SG, Felts K, Nichols WS, Geller SA, Hager JH, et al. Neonatal hepatitis induced by α1-antitrypsin: a transgenic mouse model. Science 1988;242:1409-1412.
4. Geller SA, Nichols WS, Kim S, Tolmachoff T, Lee S, Dycaico MJ, et al. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 α1-antitrypsin transgenic mice: histopathological and DNA ploidy studies. HEPATOLOGY 1994;19:389-397.
5. Carlson JA, Rogers BB, Sifers RN, Finegold MJ, Clift SM, DeMayo FJ, et al. Accumulation of PiZ antitrypsin causes liver damage in transgenic mice. J Clin Invest 1989;83:1183-1190.
6. Rudnick DA, Liao Y, An JK, Muglia LJ, Perlmutter DH, Teckman JH. Analyses of hepatocellular proliferation in a mouse model of α-1-antitrypsin deficiency. HEPATOLOGY 2004;39:1048-1055.
7. Janoff A. Elastases and emphysema: current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis 1985;132:417-433.
8. Sveger T. Liver disease in α1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976;294:1316-1321.
9. Sveger T. The natural history of liver disease in α1-antitrypsin deficient children. Acta Paediatr Scand 1988;77:847-851.
10. Lomas DA, Mahadeva R. α1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest 2002;110: 1585-1590.
11. Lomas DA, Evans DL, Finch JT, Carrell RW. The mechanism of Z α1-antitrypsin accumulation in the liver. Nature 1992;357:605-607.
12. Kim J, Lee KN, Yi GS, Yu MH. A thermostable mutation located at the hydrophobic core of α1-antitrypsin suppresses the folding defect of the Z-type variant. J Biol Chem 1995;270:8597-8601.
13. Sidhar SK, Lomas DA, Carrell RW, Foreman RC. Mutations which impede loop-sheet polymerization enhance the secretion of human α1-antitrypsin deficiency variants. J Biol Chem 1995;270:8393-8396.
14. Lin L, Schmidt B, Teckman J, Perlmutter DH. A naturally occurring non-polymerogenic mutant of α1-antitrypsin characterized by prolonged retention in the endoplasmic reticulum. J Biol Chem 2001;276:33893-33898.
15. Schmidt B, Perlmutter DH. GRP78, GRP94 and GRP170 interact with α1AT mutants that are retained in the endoplasmic reticulum. Am J Physiol Gastrointest Liver Physiol 2005(Apr 21);PMID: 15845869.
16. Wu Y, Whitman I, Molmenti E, Moore K, Hippenmeyer P, Perlmutter D. A lag in intracellular degradation of mutant α1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ α1-antitrypsin deficiency. Proc Natl Acad Sci U S A 1994;91:9014-9018.
17. Werner ED, Brodsky JL, McCracken AA. Proteasome-dependent endoplasmic reticulum-associated protein degradation: an unconventional route to a familiar fate. Proc Natl Acad Sci U S A 1996;93:13797-13801.
18. Qu D, Teckman JH, Omura S, Perlmutter DH. Degradation of mutant secretory protein, α1-antitrypsin Z, in the endoplasmtc reticulum requires proteasome activity. J Biol Chem 1996;271:22791-22795.
19. Teckman JH, Gilmore R, Perlmutter DH. Role of ubiquitin in proteasomal degradation of mutant α1-antitrypsin Z in the endoplasmic reticulum. Am J Physiol 2000;278:G39-G48.
20. Teckman JH, Burrows J, Hidvegi T, Schmidt B, Hale PD, Perlmutter DH. The proteasome participants in degradation of mutant α1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes. J Biol Chem 2001;276:44865-44872.
21. Cabrai CM, Liu Y, Moremen KW, Sifers RN. Organizational diversiry among distinct glycoprotein endoplasmic reticulum-associated degradation programs. Mol Biol Cell 2002;13:2639-2650.
22. Mayer T, Braun T, Jentsch S. Role of the proteasome in membrane extraction of a short-lived ER-transmembrane protein. EMBO J 1998;17:3251-3257.
23. Cabral CM, Choudhury P, Liu Y, Sifers RN. Processing by endoplasmic reticulum mannosidases partitions a secretion-impaired glycoprotein into distinct disposal pathways. J Biol Chem 2000;275:25015-25022.
24. Teckman JH, Perlmutter DH. Retention of mutant α1-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. Am J Physiol 2000;279:G961-G974.
25. Teckman JH, An JK, Loethen S, Perlmutter DH. Fasting in α1-antitrypsin deficient liver: constitutive activation of autophagy. Am J Physiol 2002; 283:G1156-G11165.
26. Teckman JH, An JK, Blomenkamp K, Schmidt B, Perlmutter D. Mitochondrial autophagy and injury in the liver in α1-antitrypsin deficiency. Am J Physiol 2004;286:G851-G862.
27. Zhang K, Kaufman RJ. Signaling the unfolded protein response from the endoplasmic reticulum. J Biol Chem 2004;279:25935-25938.
28. Ron D. Translational control in the endoplasmic reticulum stress response. J Clin Invest 2002;110:1383-1388.
29. Pahl HL, Sester M, Burgert HG, Baeuerle PA. Activation of transcription factor NF-KB by the adenovirus E3/19K protein requires its ER retention. J Cell Biol 1996;132:511-522.
30. Hu C, Perlmutter DH. Cell-specific involvement of HNF-1β in α1-antitrypsin gene expression in human respiratory epithelial cells. Am J Physiol 2002;282:L757-L765.
31. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-KB functions as a tumor promoter in inflammation-associated cancer. Nature 2004;431:461-466.
32. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004;118:285-296.
33. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis a cytotoxicity by amyloid-β. Nature 2000;403:98-103.
34. Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Koyama Y, et al. Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ-induced cell death. J Cell Biol 2004;165:347-356.
35. Schamel WW, Kuppig S, Becker B, Gimborn K, Hauri HP, Reth MA. A high-molecular-weight complex of membrane proteins BAP29/BAP31 is involved in the retention of membrane-bound IgD in the endoplasmic reticulum. Proc Natl Acad Sci U S A 2003;100:9861-9866.
36. Breckenridge DG, Srojanovic M, Marcellus RC, Shore GC. Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J Cell Biol 2003;160:1115-1127.
37. Geller SA, Nichols WS, Dycaico MJ, Felts KA, Sorge JA. Histopathology of α1-antitrypsin liver disease in a transgenic mouse model. HEPATOLOGY 1990;12:40-47.
38. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003;112:1809-1820.
39. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 2003;100:15077-15082.
40. Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, Diaz-Latoud C, et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2000;2:645-652.
41. Perlmutter DH, Schlesinger MJ, Pierce JA, Punsal PI, Schwartz AL. Synthesis of stress proteins is increased in individuals with homozygous PiZZ α1-antitrypsin deficiency and liver disease. J Clin Invest 1989;84:1555-1561.
42. Zhou H, Fischer H-P. Liver carcinoma in PiZ alpha-1-antitrypsin deficiency. Am J Surg Pathol 1998;22:742-748.
43. Vogel A, van Den Berg IE, Al-Dhalimy M, Groopman J, Ou CN, Ryabinina O, et al. Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death. HEPATOLOGY 2004;39:433-443.
44. Kvittingen EA, Rootwelt H, Berger R, Brandtzaeg P. Self-induced correction of the genetic defect in tyrosinemia type I. J Clin Invest 1994;94: 1657-1661.
45. Overturf K, Al-Dhalimy M, Tanguay R, Brandy M, Ou CM, Finegold M, et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat Genet 1996;12:266-273.
46. Demers SI, Russo P, Lettre F, Tanguay RM. Frequent mutation reversion inversely correlates with clinical severity in a genetic liver disease, hereditary tyrosinemia. Hum Pathol 2003;34:1313-1320.
47. McLachlan A, Milich DR, Raney AK, Riggs MG, Hughes JL, Sorge J, et al. Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences. J Virol 1987;61:683-692.
48. Wang HC, Wu HC, Chen CF, Fausto N, Lei HY, Su IJ. Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticuium stress. Am J Pathol 2003;163:2441-2449.
49. Dubuisson J. Folding, assembly and subcellular localization of hepatitis C virus glycoproteins. Curr Top Microbiol Immunol 2000;242:135-148.